{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:54:22Z","timestamp":1774932862198,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jdiacomp.2023.108408","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T17:28:52Z","timestamp":1674667732000},"page":"108408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Outcomes of 35-year duration of type 1 diabetes and proliferative diabetic retinopathy on functional vision and quality of life: Benefits of good glycemic control"],"prefix":"10.1016","volume":"37","author":[{"given":"Joonas","family":"Wirkkala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna-Maria","family":"Kubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasi","family":"Ohtonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aura","family":"Falck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Hautala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2023.108408_bb0005","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1080\/07853890.2022.2064541","article-title":"VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy","volume":"54","author":"Arrigo","year":"2022","journal-title":"Ann Med"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0010","first-page":"893","article-title":"Update on current care guideline: diabetic retinopathy","volume":"131","author":"Summanen","year":"2015","journal-title":"Duodecim"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0015","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/aos.12278","article-title":"Marked reductions in visual impairment due to diabetic retinopathy achieved by efficient screening and timely treatment","volume":"92","author":"Hautala","year":"2014","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0020","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.ophtha.2018.04.007","article-title":"Guidelines on diabetic eye care: the International Council of Ophthalmology recommendations for screening, follow-up, referral, and treatment based on resource settings","volume":"125","author":"Wong","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jamaophthalmol.2015.4606","article-title":"Effects of prior intensive insulin therapy and risk factors on patient-reported visual function outcomes in the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) Cohort","volume":"134","author":"Gubitosi-Klug","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0030","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.2337\/dc16-2723","article-title":"Risk of severe hypoglycemia in type 1 diabetes over 30 years of follow-up in the DCCT\/EDIC study","volume":"40","author":"Gubitosi-Klug","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0035","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1542\/peds.2005-0875","article-title":"Screening for retinopathy in the pediatric patient with type 1 diabetes mellitus","volume":"116","author":"Lueder","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/pedi.12112","article-title":"Puberty as an accelerator for diabetes complications","volume":"15","author":"Cho","year":"2014","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0045","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/aos.12426","article-title":"Prevalence of diabetic retinopathy in young adults with type 1 diabetes since childhood: the Oulu cohort study of diabetic retinopathy","volume":"92","author":"Hautala","year":"2014","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0050","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0161-6420(78)35693-1","article-title":"Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings","volume":"85","year":"1978","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0055","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.oret.2020.02.006","article-title":"Efficacy and side effects of individualized panretinal photocoagulation","volume":"4","author":"Vergmann","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0060","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1001\/jama.2015.15217","article-title":"Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial","volume":"314","author":"Gross","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0065","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1097\/IAE.0000000000002377","article-title":"PHOTOCOAGULATION VERSUS RANIBIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: should baseline characteristics affect choice of treatment?","volume":"39","author":"Bressler","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0070","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ophtha.2018.08.001","article-title":"Rationale and application of the protocol S anti-vascular endothelial growth factor algorithm for proliferative diabetic retinopathy","volume":"126","author":"Sun","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0075","article-title":"Efficacy and safety of ranibizumab with or without panretinal laser photocoagulation versus laser photocoagulation alone in proliferative diabetic retinopathy - the PRIDE study","author":"Lang","year":"2019","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0080","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2019-000390","article-title":"Intravitreal bevacizumab improves the clearance of vitreous haemorrhage and visual outcomes in patients with proliferative diabetic retinopathy","volume":"4","author":"Wirkkala","year":"2019","journal-title":"BMJ Open Ophthalmol"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0085","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1177\/1120672117750053","article-title":"Early glycaemic control for maintaining visual function in type 1 diabetes: the Oulu cohort study of diabetic retinopathy","volume":"28","author":"Hautala","year":"2018","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0090","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/aos.12122","article-title":"Health-related quality of life\u2013using the 15D instrument\u2013of young adults with type 1 diabetes since childhood. Population-based Oulu cohort study of diabetic retinopathy","volume":"92","author":"Hannula","year":"2014","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0095","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1755-3768.1993.tb08604.x","article-title":"Prevalence and risk factors of retinopathy in children with diabetes. A population-based study on finnish children","volume":"71","author":"Falck","year":"1993","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0100","first-page":"93","article-title":"Using reaction time in visual search and decision making task to measure visual field thresholds in multifixation perimetry","author":"Leinonen","year":"2015","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0105","doi-asserted-by":"crossref","DOI":"10.1111\/j.1755-3768.2014.2444.x","article-title":"Visual Search Test (VST) - reaction time perimetry with fixation objects detectable only by foveal vision","volume":"92","author":"Leinonen","year":"2014","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0110","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3109\/07853890109002086","article-title":"The 15D instrument of health-related quality of life: properties and applications","volume":"33","author":"Sintonen","year":"2001","journal-title":"Ann Med"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0115","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045","volume":"138","author":"Cho","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0120","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0125","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0161-6420(91)32085-2","article-title":"Long-term stability and visual outcome after favorable initial response of proliferative diabetic retinopathy to panretinal photocoagulation","volume":"98","author":"Vander","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0130","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/jamaophthalmol.2018.3255","article-title":"Five-year outcomes of panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy","volume":"136","author":"Gross","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0135","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12886-022-02482-z","article-title":"Visual outcomes of observation, macular laser and anti-VEGF in diabetic macular edema in type 1 diabetes: a real-world study","volume":"22","author":"Wirkkala","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0140","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.ophtha.2014.12.001","article-title":"Multimodal characterization of proliferative diabetic retinopathy reveals alterations in outer retinal function and structure","volume":"122","author":"Boynton","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0145","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.2337\/db13-1628","article-title":"Progression of early retinal dysfunction in diabetes over time: results of a long-term prospective clinical study","volume":"63","author":"Hellgren","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0150","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/dme.13686","article-title":"Barriers to and enablers of diabetic retinopathy screening attendance: a systematic review of published and grey literature","volume":"35","author":"Graham-Rowe","year":"2018","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0155","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/bjophthalmol-2017-310915","article-title":"Inter-relationship between visual symptoms, activity limitation and psychological functioning in patients with diabetic retinopathy","volume":"102","author":"Fenwick","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0160","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1080\/08870446.2016.1144753","article-title":"Coping with type 1 diabetes through emerging adulthood: longitudinal associations with perceived control and haemoglobin A1c","volume":"31","author":"Rassart","year":"2016","journal-title":"Psychol Health"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0165","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00592-019-01384-9","article-title":"Vision-related quality of life and locus of control in type 1 diabetes: a multicenter observational study","volume":"56","author":"Trento","year":"2019","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0170","first-page":"S - 1","article-title":"Flash glucose monitoring: the future is here","volume":"19","author":"Garg","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jdiacomp.2023.108408_bb0175","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jdiacomp.2018.05.007","article-title":"What are the clinical, quality-of-life, and cost consequences of 30 years of excellent vs. poor glycemic control in type 1 diabetes?","volume":"32","author":"Herman","year":"2018","journal-title":"J Diabetes Complications"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872723000065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872723000065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:17:21Z","timestamp":1761005841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872723000065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1056872723000065"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2023.108408","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of 35-year duration of type 1 diabetes and proliferative diabetic retinopathy on functional vision and quality of life: Benefits of good glycemic control","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2023.108408","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023","name":"copyright","label":"Copyright"}],"article-number":"108408"}}